No survival difference between super extended and standard lymph node dissection at radical cystectomy: what can we learn from the first prospective randomized phase III trial?
Transl Androl Urol
.
2019 Mar;8(Suppl 1):S112-S115.
doi: 10.21037/tau.2018.12.09.
Authors
Tim Muilwijk
1
,
Murat Akand
2
,
Thomas Gevaert
3
,
Steven Joniau
1
Affiliations
1
Department of Urology, University Hospitals Leuven, Leuven, Belgium.
2
School of Medicine, Department of Urology, Selcuk University, Konya, Turkey.
3
Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
PMID:
31143684
PMCID:
PMC6511709
DOI:
10.21037/tau.2018.12.09
No abstract available
Publication types
Editorial
Comment